Jacob A. Orville - Aug 5, 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
EVP, GM, Screening
Signature
/s/ Jacob A. Orville by Mark Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Aug 5, 2024
Transactions value $
$0
Form type
4
Date filed
8/6/2024, 05:30 PM
Previous filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXAS Common Stock 14.4K Aug 5, 2024 Direct F1
holding EXAS Common Stock 1.12K Aug 5, 2024 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Award $0 +21.4K $0.00 21.4K Aug 5, 2024 Common Stock 21.4K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In addition to the shares of Common Stock reported on this Form 4, which total 15,557 shares, Mr. Orville also holds, in the aggregate, an additional 72,107 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 These restricted stock units vest in four equal annual installments beginning on August 5, 2025.